Glutathione-SR by Thorne Research - New sustained release formula!
The process of aging is associated with increased oxidative activity and decreased levels of reduced glutathione. This appears to be especially prominent in individuals experiencing a decline in cognitive function.
Conversely, those living over 100 years tend to have higher glutathione reductase activity.
Glutathione, as an important intracellular antioxidant, plays a crucial role in preventing free-radical-induced lipid peroxidation. Hepatic tissue contains a high level of glutathione, mainly in its reduced form. May be useful for individuals sensitive to chemicals and/or heavy metals, especially mercury.
Research suggests that glutathione supplementation may be useful as supportive therapy in conditions such as:
- Alcoholism
- Alzheimer's
- Asthma
- Autism
- cancer
- cardiovascular disease
- chronic fatigue
- degenerative diseases of aging
- diabetes
- macular degeneration
- mercury toxicity
- Parkinson's
Patent-pending Glutathione-SR from Thorne Research represents a breakthrough in glutathione supplementation. Its sustained release properties protect it from break down by stomach acid and digestive enzymes.
